Obstetric hemorrhage and coagulation: An update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage

Obstetrical and Gynecological Survey

Volumn 67, Issue 7, 2012, Pages 426-435

  De Lange, Natascha M ^a   Lancé, Marcus D ^b   De Groot, Renée ^b   Beckers, Erik A M ^b   Henskens, Yvonne M ^b   Scheepers, Hubertina C J ^c  

^a Sittard Geleen Heerlen   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRIN; FIBRINOGEN; FRESH FROZEN PLASMA; HETASTARCH; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RINGER LACTATE SOLUTION; TRANEXAMIC ACID;

ASSAY; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; BLOOD VOLUME; CLINICAL PROTOCOL; COLLOID; COST EFFECTIVENESS ANALYSIS; DILUTION; DILUTIONAL BLOOD CLOTTING DISORDER; DISEASE COURSE; DISEASE SEVERITY; EARLY INTERVENTION; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FIBRIN POLYMERIZATION; FLUID RESUSCITATION; GYNECOLOGIC SURGERY; HEMOSTASIS; HUMAN; HYPERVOLEMIA; HYPOFIBRINOGENEMIA; LABOR STAGE 3; MATERNAL MORTALITY; META ANALYSIS; POSTOPERATIVE HEMORRHAGE; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANT WOMAN; PROGNOSIS; PROTHROMBIN TIME; REVIEW; RISK FACTOR; SIDE EFFECT; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; THROMBOELASTOMETRY; THROMBOSIS;

EID: 84864450589     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3182605861     Document Type: Review

References (86)

1. World Health Organisation. The World Health Report 2005VMake Every Mother and Child Count. Geneva, Switzerland: World Health Organisation; 2005.
2. Berg C, Harper M, Atkinson S, et al. Preventability of pregnancy-related deaths: results of a state-wide review. Obstet Gynecol. 2005;106:1228-1234.
3. Schutte J, Steegers E, Schuitemaker N, et al. Rise in maternal mortality in the Netherlands. Br J Obstet Gynaecol. 2010;117:399-406.
4. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006;108: 1039-1047.
5. McLintock C. Obstetric haemorrhage. Thromb Res. 2009; 123(suppl 2):S30YS34.
6. Leduc D, Senikas V, Lalonde AB, et al. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can. 2009;31: 980-993.
7. Wise A, Clark V. Strategies to manage major obstetric haemorrhage. Curr Opin Anaesthesiol. 2008;21:281-287.
8. Ahonen J, Stefanovic V, Lassila R. Management of postpartum haemorrhage. Acta Anaesthesiol Scand. 2010;54:1164-1178.
9. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009;9:55.
10. Theusinger OM, Spahn DR, Ganter MT. Transfusion in trauma: why and how should we change our current practice? Curr Opin Anaesthesiol. 2009;22:305-312.
11. Spalding G, Hartrumpf M, Sierig T, et al. Cost reduction of perioperative coagulation management in cardiac surgery: value of 'bedside' thrombelastography (ROTEM). Eur J Cardiothorac Surg. 2007;31:1052-1057.
12. Innerhofer P, Streif W, Kuhbacher G, et al. Monitoring of perioperative dilutional coagulopathy using the ROTEM analyzer: basic principles and clinical examples in German. Anasthesiol Intensivmed Notfallmed Schmerzther. 2004; 39:739-744.
13. Rossaint R, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care. 2010;14:R52.
14. Hoffman M, Monroe DM. Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am. 2007;21:1-11.
15. Hoffman M. Remodeling the blood coagulation cascade. J Thromb Thrombolysis. 2003;16(1-2):17-20.
16. Smith SA. The cell-based model of coagulation. J Vet Emerg Crit Care (San Antonio). 2009;19:3-10.
17. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114:1326-1331.
18. Cerneca F, Ricci G, Simeone R, et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol. 1997;73:31-36.
19. Franchini M. Post-partum hemorrhage: new therapeutic options in Italian. Recenti Prog Med. 2007;98:7-11.
20. Szecsi PB, Jorgensen M, Klajnbard A, et al. Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010; 103:718-727.
21. Choi J, Pai S. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy. Ann Hematol. 2002;81:611-615.
22. Francalanci I, Comeglio P, Liotta AA, et al. D-Dimer concentrations during normal pregnancy, as measured by ELISA. Thromb Res. 1995;78:399-405.
23. O'Riordan MN, Higgins Jr. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol. 2003;17:385-396.
24. Francalanci I, Comeglio P, Liotta A, et al. D-Dimer concentrations durig normal pregnancy, as measured by ELISA. Thromb Res. 1995;78:399-405.
25. Kline J, Williams G, Hernandez-Nino J. D-Dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clin Chem. 2005;51:825-829.
26. MacPhail S, Talks K. Massive post-partum haemorrhage and management of disseminated intravascular coagulation. Curr Obstet Gynaecol. 2004;14:123-131.
27. Hamilton-Davies C, Mythen MG, Salmon JB, et al. Comparison of commonly used clinical indicators of hypovolaemia with gastrointestinal tonometry. Intensive Care Med. 1997;23: 276-281.
28. Stafford I, Dildy GA, Clark SL, et al. Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol. 2008;199:519.e1-519.e7.
29. Johansson PI, Ostrowski SR, Secher NH. Management of major blood loss: an update. Acta Anaesthesiol Scand. 2010;54:1039-1049.
30. Spahn DR, Cerny V, Coats TJ, et al. Management of bleeding following major trauma: a European guideline. Crit Care. 2007; 11:R17.
31. Burtelow M, Riley E, Druzin M, et al. How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion. 2007; 47:1564-1572.
32. Al Kadri HM. Obstetric medical emergency teams are a step forward in maternal safety! J Emerg Trauma Shock. 2010;3: 337-341.
33. Merien AE, van de Ven J, Mol BW, et al. Multidisciplinary team training in a simulation setting for acute obstetric emergencies: a systematic review. Obstet Gynecol. 2010; 115:1021-1031.
34. Howell C, Grady K, Cox C, eds. The MOET Course Manual: Managing Obstetric Emergencies and Trauma. 2nd ed. London, UK: RCOG Press; 2009.
35. Skupski DW, Lowenwirt IP, Weinbaum FI, et al. Improving hospital systems for the care of women with major obstetric hemorrhage. Obstet Gynecol. 2006;107:977-983.
36. Varatharajan L, Chandraharan E, Sutton J, et al. Outcome of the management of massive postpartum hemorrhage using the algorithm "HEMOSTASIS." Int J Gynaecol Obstet. 2011;113: 152-154.
37. James AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia. 2005;11:295-307.
38. James AH, Jamison MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J ThrombHaemost. 2007;5:1165-1169.
39. Al-Zirqi I, Vangen S, Forsen L, et al. Prevalence and risk factors of severe obstetric haemorrhage. BJOG. 2008;115:1265-1272.
40. Chauleur C, Cochery-Nouvellon E, Mercier E, et al. Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages. J Thromb Haemost. 2008;6:2067-2074.
41. Chee YL, Crawford JC, Watson HG, et al. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol. 2008;140:496-504.
42. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol. 2009;22:267-274.
43. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology. 2005;103:654-660.
44. Westphal M, James MF, Kozek-Langenecker S, et al. Hydoxylethyl starches. Anesthesiology. 2009;111:187-202.
45. Mittermayr M, Streif W, Haas T, et al. Hemostatic changes after crystalloid od colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg. 2007;105:905-917.
46. Mittermayr M, Streif W, Haas T, et al. Effect of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasmingen activator added ex vivo. Br J Anaesth. 2008; 100:307-314.
47. Spahn DR, Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth. 2005;95:130-139.
48. Cosgriff N, Moore EE, Sauaia A, et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma. 1997;42:857-861; discussion 861-862.
49. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost. 2005;3:2607-2611.
50. Schols SE, Lance MD, Feijge MA, et al. Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery. Thromb Haemost. 2010;103:318-328.
51. Zink KA,SambasivanCN, HolcombJB, et al.Ahigh ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg. 2009;197:565-570; discussion 570.
52. Duchesne JC, Hunt JP, Wahl G, et al. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years? J Trauma. 2008;65:272-276; discussion 276-278.
53. Duchesne JC, Islam TM, Stuke L, et al. Hemostatic resuscitation during surgery improves survival in patients with traumaticinduced coagulopathy. J Trauma. 2009;67:33-37; discussion 37-39.
54. Reid RW, Zimmerman AA, Laussen PC, et al. The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg. 1997;84:990-996.
55. Dryden PJ, O'Connor JP, Jamieson WR, et al. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery. Can J Anaesth. 1997;44:934-941.
56. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000; (4):CD000249.
57. Novikova N, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2010;(7):CD007872.
58. Shakur H, Elbourne D, Gulmezoglu M, et al. The WOMAN trial (World Maternal Antifibrinolytic trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010;11:40.
59. Mercier FJ, Bonnet MP. Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage. Curr Opin Anaesthesiol. 2010;23:310-316.
60. Levi M, Levy JH, Andersen HF, et al. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363:1791-1800.
61. Pacheco LD, Saade GR, Gei AF, et al. Cutting-edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol. 2011;205:526-532.
62. Ickx BE. Fluid and blood transfusion management in obstetrics. Eur J Anaesthesiol. 2010;27:1031-1035.
63. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5:266-273.
64. Gayat E, Resche-Rigon M, Morel O, et al. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med. 2011; 37:1816-1825.
65. Bell SF, Rayment R, Collins PW, et al. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth. 2010;19:218-223.
66. Kozek-Langenecker S, Sorensen B, Hess J, et al. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care. 2011;15:R239.
67. Available at: http://www.haemonetics.com.
68. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol. 2005;27:81-90.
69. Available at: http://www.rotem.de/.
70. PolakF, LipsM,BedrichovaH, et al. The use of thrombelastography in evaluation of coagulation in females with physiological or pathological gravidity in Czech. Cas Lek Cesk. 2007; 146:396-400.
71. Sharma SK, Philip J, Wiley J. Thromboelastographic changes in healthy parturients and postpartum women. Anesth Analg. 1997;85:94-98.
72. Armstrong S, Fernando R, Ashpole K, et al. Assessment of coagulation in the obstetric population using ROTEM\ thromboelastometry. Int J Obstet Anesth. 2011;20:293-298.
73. Huissoud C, Carrabin N, Benchaib M, et al. Coagulation assessment by rotation thrombelastometry in normal pregnancy. Thromb Haemost. 2009;101:755-761.
74. Oudghiri M, Keita H, Kouamou E, et al. Reference values for rotation thromboelastometry (ROTEM\) parameters following non-haemorrhagic deliveries. Correlations with standard haemostasis parameters. Thromb Haemost. 2011;106:176-178.
75. Butwick A, Carvalho B. The effect of colloid and crystalloid preloading on thromboelastography prior to cesarean delivery. Can J Anaesth. 2007;54:190-195.
76. Turker G, Yilmazlar T, Mogol EB, et al. The effects of colloid pre-loading on thromboelastography prior to caesarean delivery: hydroxyethyl starch 130/0.4 versus succinylated gelatine. J Int Med Res. 2011;39:143-149.
77. Ansari T, Riad W. The effect of haemodilution with 6% hydroxyethyl starch (130/0.4) on haemostasis in pregnancy: an in-vitro assessment using thromboelastometry. Eur J Anaesthesiol. 2010;27:304-305.
78. Butwick A, Ting V, Ralls LA, et al. The association between thromboelastographic parameters and total estimated blood loss in patients undergoing elective cesarean delivery. Anesth Analg. 2011;112:1041-1047.
79. Huissoud C, Carrabin N, Audibert F, et al. Bedside assessment of f ibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG. 2009;116:1097-1102.
80. Bauters A, Ducloy-Bouthors A, Lejeune C, et al. ROTEM\ thromboelastometry in obstetric: near patient-test as an early predictor of post-partum hemorrhage (PPH). J Thromb Haemost. 2007;5(suppl 2). Abstract P-S-220.
81. SwallowRA,AgarwalaRA,DawkinsKD,etal.Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy? Platelets. 2006;17:385-392.
82. Larsen OH, Fenger-Eriksen C, Christiansen K, et al. Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents. Anesthesiology. 2011;115:294-302.
83. Scharbert G, Auer A, Kozek-Langenecker S. Evaluation of the platelet mapping assay on rotational thromboelastometry ROTEM. Platelets. 2009;20:125-130.
84. Lang T, Johanning K, Metzler H, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg. 2009;108:751-758.
85. Johansson PI, Stissing T, Bochsen L, et al. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med. 2009;17:45.
86. Douning LK, Ramsay MA, Swygert TH, et al. Temperature corrected thrombelastography in hypothermic patients. Anesth Analg. 1995;81:608-611.